Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications
Mesenchymal stem cells (MSCs) have shown their therapeutic potency for treatment of cardiovascular diseases owing to their low immunogenicity, ease of isolation and expansion, and multipotency. As multipotent progenitors, MSCs have revealed their ability to differentiate into various cell types and...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/1314709 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832555419357151232 |
---|---|
author | Hongyan Tao Zhibo Han Zhong Chao Han Zongjin Li |
author_facet | Hongyan Tao Zhibo Han Zhong Chao Han Zongjin Li |
author_sort | Hongyan Tao |
collection | DOAJ |
description | Mesenchymal stem cells (MSCs) have shown their therapeutic potency for treatment of cardiovascular diseases owing to their low immunogenicity, ease of isolation and expansion, and multipotency. As multipotent progenitors, MSCs have revealed their ability to differentiate into various cell types and could promote endogenous angiogenesis via microenvironmental modulation. Studies on cardiovascular diseases have demonstrated that transplanted MSCs could engraft at the injured sites and differentiate into cardiomyocytes and endothelial cells as well. Accordingly, several clinical trials using MSCs have been performed and revealed that MSCs may improve relevant clinical parameters in patients with vascular diseases. To fully comprehend the characteristics of MSCs, understanding their intrinsic property and associated modulations in tuning their behaviors as well as functions is indispensable for future clinical translation of MSC therapy. This review will focus on recent progresses on endothelial differentiation and potential clinical application of MSCs, with emphasis on therapeutic angiogenesis for treatment of cardiovascular diseases. |
format | Article |
id | doaj-art-4fc577b6b0264eaba6fa7b81d84f2429 |
institution | Kabale University |
issn | 1687-966X 1687-9678 |
language | English |
publishDate | 2016-01-01 |
publisher | Wiley |
record_format | Article |
series | Stem Cells International |
spelling | doaj-art-4fc577b6b0264eaba6fa7b81d84f24292025-02-03T05:48:16ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/13147091314709Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic ApplicationsHongyan Tao0Zhibo Han1Zhong Chao Han2Zongjin Li3Department of Pathophysiology, Nankai University School of Medicine, Tianjin 300071, ChinaState Key Lab of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin 300020, ChinaState Key Lab of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin 300020, ChinaDepartment of Pathophysiology, Nankai University School of Medicine, Tianjin 300071, ChinaMesenchymal stem cells (MSCs) have shown their therapeutic potency for treatment of cardiovascular diseases owing to their low immunogenicity, ease of isolation and expansion, and multipotency. As multipotent progenitors, MSCs have revealed their ability to differentiate into various cell types and could promote endogenous angiogenesis via microenvironmental modulation. Studies on cardiovascular diseases have demonstrated that transplanted MSCs could engraft at the injured sites and differentiate into cardiomyocytes and endothelial cells as well. Accordingly, several clinical trials using MSCs have been performed and revealed that MSCs may improve relevant clinical parameters in patients with vascular diseases. To fully comprehend the characteristics of MSCs, understanding their intrinsic property and associated modulations in tuning their behaviors as well as functions is indispensable for future clinical translation of MSC therapy. This review will focus on recent progresses on endothelial differentiation and potential clinical application of MSCs, with emphasis on therapeutic angiogenesis for treatment of cardiovascular diseases.http://dx.doi.org/10.1155/2016/1314709 |
spellingShingle | Hongyan Tao Zhibo Han Zhong Chao Han Zongjin Li Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications Stem Cells International |
title | Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications |
title_full | Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications |
title_fullStr | Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications |
title_full_unstemmed | Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications |
title_short | Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications |
title_sort | proangiogenic features of mesenchymal stem cells and their therapeutic applications |
url | http://dx.doi.org/10.1155/2016/1314709 |
work_keys_str_mv | AT hongyantao proangiogenicfeaturesofmesenchymalstemcellsandtheirtherapeuticapplications AT zhibohan proangiogenicfeaturesofmesenchymalstemcellsandtheirtherapeuticapplications AT zhongchaohan proangiogenicfeaturesofmesenchymalstemcellsandtheirtherapeuticapplications AT zongjinli proangiogenicfeaturesofmesenchymalstemcellsandtheirtherapeuticapplications |